GXST capsule can delay the progression of atherosclerosis by regulating lipid profile and downregulating the levels of inflammatory cytokines [e.g., TNF-α, IL-1β, IL-6, and Intercellular Cell Adhesion Molecule-1 (ICAM-1)] and Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 (43, 44). The gene discussed is NFKB1; the disease is atherosclerosis.